Designing specific chemotherapy delivery systems that target cancer cells is widely studied nowadays.Different substitutions of tellurium (Te)/vanadate (V) doped hydroxyapatite (HAP) have been suggested to be used as a carrier scaffold for doxorubicin (DOX).In contrast, the ultimated scaffold is coated with chitosan (CS) to be utilized and studied as a colon cancer therapy.Evaluation of DOX releas...